کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8925926 | 1643640 | 2017 | 17 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Therapies for non-alcoholic steatohepatitis
ترجمه فارسی عنوان
درمان برای استاتو هپاتیت غیر الکلی
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
کبدشناسی
چکیده انگلیسی
Current phase 3 trials for the treatment of non-alcoholic steatohepatitis (NASH) are discussed in this review. Modalities that are based on weight loss include therapeutic lifestyle changes, pharmacological weight loss drugs (e.g., orlistat), and bariatric surgery. Traditionally, insulin resistance has been targeted using pioglitazone, but liraglutide and elafibranor are emerging as potential treatments. With regard to the farnesoid X receptor (FXR) pathway, obeticholic acid has been approved for primary biliary cholangitis and is being studied as a treatment for NASH. Antioxidants include vitamin E and statins. Medications that target fibrogenesis directly instead of NASH include selonsertib.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Liver Research - Volume 1, Issue 4, December 2017, Pages 214-220
Journal: Liver Research - Volume 1, Issue 4, December 2017, Pages 214-220
نویسندگان
Winston Dunn,